Literature DB >> 2418960

Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium.

G D Shipley, M R Pittelkow, J J Wille, R E Scott, H L Moses.   

Abstract

Type beta transforming growth factor-growth inhibitor (TGF beta/GI) causes normal human prokeratinocytes to arrest growth predominantly in the G1 phase of the cell cycle within 48 h after log phase cultures are exposed to the factor in serum-free medium. The growth arrest induced by TGF beta/GI is reversible because the cells from treated cultures can be replated into fresh medium and grown into large colonies. Normal prokeratinocytes are demonstrated to secrete TGF beta/GI-like molecules into the culture medium and to have specific cell surface receptors for this molecule. In contrast, a human squamous cell carcinoma, SCC-25, does not arrest growth when exposed to TGF beta/GI. These cells, unlike the normal prokeratinocytes, do not exhibit detectable cell surface receptors for the factor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2418960

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  103 in total

1.  Modulation of the growth and morphology of a human nasopharyngeal carcinoma cell line by growth factors.

Authors:  J K Chen; Y S Chang; S S Lin; H H Chao
Journal:  In Vitro Cell Dev Biol       Date:  1992 Sep-Oct

Review 2.  TGF-beta: problems and prospects.

Authors:  M B Sporn; A B Roberts
Journal:  Cell Regul       Date:  1990-11

Review 3.  Growth inhibitors: molecular diversity and roles in cell proliferation.

Authors:  K Miyazaki; T Horio
Journal:  In Vitro Cell Dev Biol       Date:  1989-10

Review 4.  The family feud: turning off Sp1 by Sp1-like KLF proteins.

Authors:  Gwen Lomberk; Raul Urrutia
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

5.  Novel functional single nucleotide polymorphisms in the latent transforming growth factor-beta binding protein-1L promoter: effect on latent transforming growth factor-beta binding protein-1L expression level and possible prognostic significance in ovarian cancer.

Authors:  Tomomi Higashi; Satoru Kyo; Masaki Inoue; Hideji Tanii; Kiyofumi Saijoh
Journal:  J Mol Diagn       Date:  2006-07       Impact factor: 5.568

6.  A keratinocyte hypermotility/growth-arrest response involving laminin 5 and p16INK4A activated in wound healing and senescence.

Authors:  Easwar Natarajan; John D Omobono; Zongyou Guo; Susan Hopkinson; Alexander J F Lazar; Thomas Brenn; Jonathan C Jones; James G Rheinwald
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

7.  Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion.

Authors:  A B Glick; A B Kulkarni; T Tennenbaum; H Hennings; K C Flanders; M O'Reilly; M B Sporn; S Karlsson; S H Yuspa
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

8.  Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice.

Authors:  K Sellheyer; J R Bickenbach; J A Rothnagel; D Bundman; M A Longley; T Krieg; N S Roche; A B Roberts; D R Roop
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

9.  TGF-β regulation of gene expression at early and late stages of HPV16-mediated transformation of human keratinocytes.

Authors:  Sangeeta Kowli; Rupa Velidandla; Kim E Creek; Lucia Pirisi
Journal:  Virology       Date:  2013-09-19       Impact factor: 3.616

10.  Inhibition of TGF-β signaling promotes expansion of human epidermal keratinocytes in feeder cell co-culture.

Authors:  Daisuke Suzuki; Filipa Pinto; Makoto Senoo
Journal:  Wound Repair Regen       Date:  2017-05-16       Impact factor: 3.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.